Aether Pulse
FeaturesPeptide LibraryStack BuilderDose CalculatorResearchMarketplaceCommunity
Sign inStart Free
Peptide Library
MetabolicOzempicWegovy

Semaglutide

A long-acting GLP-1 receptor agonist studied for glucose regulation and body weight.

Add to a stack

Half-life

~7 days

Schedule

weekly

Cycle

12–52 wks

Mechanism of action

Mimics GLP-1, enhancing glucose-dependent insulin secretion, slowing gastric emptying and reducing appetite.

Potential applications

Glucose researchAppetite & weight

Dosing information

Clinical titration schedules escalate weekly dosing slowly to manage tolerability.

For research and educational reference only — not a dosing recommendation.

Compatibility & stacks

Tirzepatide

Both are incretin agonists with overlapping mechanism; concurrent use is not a studied combination.

Avoid

Research references

Aether Pulse provides educational and research information only. Content is not medical advice. Products are sold for research use only. Consult a qualified professional before making health decisions.